Evidence map›Paper›PMID 39147901›Full record

ReviewFunctional & integrative genomics2024

The impact and future of artificial intelligence in medical genetics and molecular medicine: an ongoing revolution.

Firat Ozcelik, Mehmet Sait Dundar, A Baki Yildirim, Gary Henehan, Oscar Vicente, José A Sánchez-Alcázar, Nuriye Gokce, Duygu T Yildirim, Nurdeniz Nalbant Bingol, Dijana Plaseska Karanfilska and 36 more

Abstract readReview
PubMed Publisher
In one paragraph

Review in Functional & integrative genomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Firat Ozcelik *Department of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Mehmet Sait Dundar *Department of Electrical and Computer Engineering, Graduate School of Engineering and Sciences, Abdullah Gul University, Kayseri, Turkey.
A Baki YildirimDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Gary HenehanSchool of Food Science and Environmental Health, Technological University of Dublin, Dublin, Ireland.
Oscar VicenteInstitute for the Conservation and Improvement of Valencian Agrodiversity (COMAV), Universitat Politècnica de València, Valencia, Spain.
José A Sánchez-AlcázarCentro de Investigación Biomédica en Red: Enfermedades Raras, Centro Andaluz de Biología del Desarrollo (CABD-CSIC-Universidad Pablo de Olavide), Instituto de Salud Carlos III, Sevilla, Spain.
Nuriye GokceDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Duygu T YildirimDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Nurdeniz Nalbant BingolDepartment of Translational Medicine, Institute of Health Sciences, Bursa Uludag University, Bursa, Turkey.
Dijana Plaseska KaranfilskaResearch Centre for Genetic Engineering and Biotechnology, Macedonian Academy of Sciences and Arts, Skopje, Macedonia.
Matteo BertelliMAGI'S LAB, Overeto, Italy.
Lejla PojskicInstitute for Genetic Engineering and Biotechnology, University of Sarajevo, Sarajevo, Bosnia and Herzegovina.
Mehmet ErcanDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Miklos KellermayerDepartment of Biophysics and Radiation Biology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
Izem Olcay SahinDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Ole K Greiner-TollersrudInstitute of Medical Biology, UiT The Arctic University of Norway, Tromsø, Norway.
Busra TanDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Donald MartinUniversity Grenoble Alpes, CNRS, TIMC-IMAG/SyNaBi (UMR 5525), Grenoble, France.
Robert MarksAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
Satya PrakashDepartment of Biomedical Engineering, University of McGill, Montreal, QC, Canada.
Mustafa YakubiDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey.
Tommaso BeccariDepartment of Pharmeceutical Sciences, University of Perugia, Perugia, Italy.
Ratnesh LalNeuroscience Research Institute, University of California, Santa Barbara, USA.
Sehime G TemelDepartment of Translational Medicine, Institute of Health Sciences, Bursa Uludag University, Bursa, Turkey.
Isabelle FournierRéponse Inflammatoire et Spectrométrie de Masse-PRISM, University of Lille, Lille, France.
M Cerkez ErgorenDepartment of Medical Genetics, Near East University Faculty of Medicine, Nicosia, Cyprus.
Adam MechlerDepartment of Chemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia.
Michel SalzetRéponse Inflammatoire et Spectrométrie de Masse-PRISM, University of Lille, Lille, France.
Michele MaffiaDepartment of Experimental Medicine, University of Salento, Via Lecce-Monteroni, Lecce, 73100, Italy.
Dancho DanalevUniversity of Chemical Technology and Metallurgy, Sofia, Bulgaria.
Qun SunDepartment of Food Science and Technology, Sichuan University, Chengdu, China.
Lembit NeiSchool of Engineering Tallinn University of Technology, Tartu College, Tartu, Estonia.
Daumantas MatulisDepartment of Biothermodynamics and Drug Design, Institute of Biotechnology, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Dana TapaloagaFaculty of Veterinary Medicine, University of Agronomic Sciences and Veterinary Medicine of Bucharest, Bucharest, Romania.
Andres JaneckeDepartment of Paediatrics I, Medical University of Innsbruck, Innsbruck, Austria.
James BownSchool of Science, Engineering and Technology, Abertay University, Dundee, UK.
Karla Santa CruzDepartment of Physics, University of Sonora, Hermosillo, Mexico.
Iza RadeckaSchool of Science, Faculty of Science and Engineering, University of Wolverhampton, Wolverhampton, UK.
Celal OzturkDepartment of Software Engineering, Erciyes University, Kayseri, Turkey.
Ozkan Ufuk NalbantogluDepartment of Computer Engineering, Engineering Faculty, Erciyes University, Kayseri, Turkey.
Sebnem Ozemri SagDepartment of Medical Genetics, Bursa Uludag University Faculty of Medicine, Bursa, Turkey.
Kisung KoDepartment of Medicine, College of Medicine, Chung-Ang University, Seoul, Korea.
Reynir ArngrimssonIceland Landspitali University Hospital, University of Iceland, Reykjavik, Iceland.
Isabel BeloCentre of Biological Engineering, University of Minho, Braga, Portugal.
Hilal AkalinDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey. h_akaln@yahoo.com.
Munis DundarDepartment of Medical Genetics, Faculty of Medicine, Erciyes University, Kayseri, Turkey. dundar@erciyes.edu.tr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) platforms have emerged as pivotal tools in genetics and molecular medicine, as in many other fields. The growth in patient data, identification of new diseases and phenotypes, discovery of new intracellular pathways, availability of greater sets of omics data, and the need to continuously analyse them have led to the development of new AI platforms. AI continues to weave its way into the fabric of genetics with the potential to unlock new discoveries and enhance patient care. This technology is setting the stage for breakthroughs across various domains, including dysmorphology, rare hereditary diseases, cancers, clinical microbiomics, the investigation of zoonotic diseases, omics studies in all medical disciplines. AI's role in facilitating a deeper understanding of these areas heralds a new era of personalised medicine, where treatments and diagnoses are tailored to the individual's molecular features, offering a more precise approach to combating genetic or acquired disorders. The significance of these AI platforms is growing as they assist healthcare professionals in the diagnostic and treatment processes, marking a pivotal shift towards more informed, efficient, and effective medical practice. In this review, we will explore the range of AI tools available and show how they have become vital in various sectors of genomic research supporting clinical decisions.

Indexed as

Artificial IntelligenceMolecular MedicineGenetics, MedicalGenomicsHumansPrecision MedicineArtificial intelligenceDiagnosticMolecular geneticsOmicsTherapy

Identifiers

PMID39147901

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.